1. Home
  2. IOVA vs NBTB Comparison

IOVA vs NBTB Comparison

Compare IOVA & NBTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IOVA
  • NBTB
  • Stock Information
  • Founded
  • IOVA 2007
  • NBTB 1856
  • Country
  • IOVA United States
  • NBTB United States
  • Employees
  • IOVA N/A
  • NBTB N/A
  • Industry
  • IOVA Biotechnology: Biological Products (No Diagnostic Substances)
  • NBTB Major Banks
  • Sector
  • IOVA Health Care
  • NBTB Finance
  • Exchange
  • IOVA Nasdaq
  • NBTB Nasdaq
  • Market Cap
  • IOVA 2.6B
  • NBTB 2.4B
  • IPO Year
  • IOVA N/A
  • NBTB N/A
  • Fundamental
  • Price
  • IOVA $7.72
  • NBTB $51.35
  • Analyst Decision
  • IOVA Strong Buy
  • NBTB Buy
  • Analyst Count
  • IOVA 9
  • NBTB 6
  • Target Price
  • IOVA $23.33
  • NBTB $48.17
  • AVG Volume (30 Days)
  • IOVA 5.4M
  • NBTB 183.4K
  • Earning Date
  • IOVA 11-07-2024
  • NBTB 01-21-2025
  • Dividend Yield
  • IOVA N/A
  • NBTB 2.67%
  • EPS Growth
  • IOVA N/A
  • NBTB 0.14
  • EPS
  • IOVA N/A
  • NBTB 2.85
  • Revenue
  • IOVA $90,858,000.00
  • NBTB $538,802,000.00
  • Revenue This Year
  • IOVA $13,758.71
  • NBTB N/A
  • Revenue Next Year
  • IOVA $171.64
  • NBTB $17.27
  • P/E Ratio
  • IOVA N/A
  • NBTB $17.97
  • Revenue Growth
  • IOVA 12751.20
  • NBTB 10.23
  • 52 Week Low
  • IOVA $6.70
  • NBTB $32.79
  • 52 Week High
  • IOVA $18.33
  • NBTB $52.39
  • Technical
  • Relative Strength Index (RSI)
  • IOVA 34.10
  • NBTB 58.95
  • Support Level
  • IOVA $7.64
  • NBTB $50.74
  • Resistance Level
  • IOVA $8.14
  • NBTB $52.44
  • Average True Range (ATR)
  • IOVA 0.36
  • NBTB 1.16
  • MACD
  • IOVA -0.07
  • NBTB -0.03
  • Stochastic Oscillator
  • IOVA 4.26
  • NBTB 70.16

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.

About NBTB NBT Bancorp Inc.

NBT Bancorp Inc is a financial holding company that operates through its subsidiaries. The company's principal sources of revenue include management fees and dividends it receives through its subsidiaries. NBT Bank is a full-service community bank offering a full range of retail and commercial banking products and trust and investment services. Loan products include consumer, home equity, mortgage, business banking, and commercial loans. Nearly half of its loan portfolio is in commercial loans. The bank serves individuals, corporations, and municipalities, and operates scores of locations throughout New York, Pennsylvania, Vermont, Massachusetts, New Hampshire, and Maine.

Share on Social Networks: